サマリー

世界の蕁麻疹治療薬市場 2022-2026 年
Technavioは蕁麻疹治療薬市場を監視しており、2022-2026年の間に13億1000万ドルの成長が見込まれ、予測期間中にCAGR 10.35%で加速しています。当レポートでは、蕁麻疹治療薬市場の全体分析、市場規模・予測、トレンド、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、蕁麻疹の発生率の増加、蕁麻疹患者の管理に関するガイドライン、蕁麻疹用医薬品の承認の増加によって牽引されています。
蕁麻疹治療薬市場の分析には、用途別セグメントと地理的展望が含まれます。
Technavioの蕁麻疹治療薬市場は、以下のようにセグメント化されています。
用途別
- 急性蕁麻疹
- 慢性蕁麻疹
地域別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間における蕁麻疹治療薬市場の成長を促進する主要な理由の一つとして、蕁麻疹の治療に生物製剤が導入されることを挙げています。また、蕁麻疹の診断と管理に関する国際的なガイドラインや研究費の増加が、市場の大きな需要につながると考えられます。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。蕁麻疹治療薬市場に関する当レポートの対象領域は以下の通りです。
- 蕁麻疹治療薬市場のサイジング
- 蕁麻疹治療薬市場の予測
- 蕁麻疹治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Allakos Inc.、Amneal Pharmaceuticals Inc、Aurobindo Pharma Ltd、Bayer AG、F. Hoffmann La Roche Ltd、Genentech Inc、GlaxoSmithKline Plc、Johnson and Johnson、明治ホールディングス株式会社、Novartis Inc.を含むいくつかの主要蕁麻疹薬市場ベンダーについての詳細分析を提供しています。大塚製薬株式会社、ノバルティス株式会社、大塚ホールディングス株式会社、サノフィ株式会社、株式会社テラ・ファーマシューティカルズ。Ltd.、Sanofi、TerSera Therapeutics LLC、Teva Pharmaceutical Industries Ltd.、United BioPharma Inc.、Viatris Inc.の7社です。また、蕁麻疹治療薬市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/urticaria-drugs-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Application
o 5.1 Market segments
o Exhibit 24: Chart on Application - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
o 5.2 Comparison by Application
o Exhibit 26: Chart on Comparison by Application
o Exhibit 27: Data Table on Comparison by Application
o 5.3 Acute urticaria - Market size and forecast 2021-2026
o Exhibit 28: Chart on Acute urticaria - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Acute urticaria - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Acute urticaria - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Acute urticaria - Year-over-year growth 2021-2026 (%)
o 5.4 Chronic urticaria - Market size and forecast 2021-2026
o Exhibit 32: Chart on Chronic urticaria - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Chronic urticaria - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Chronic urticaria - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Chronic urticaria - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Application
o Exhibit 36: Market opportunity by Application ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share by geography 2021-2026 (%)
o Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity by geography
o Exhibit 78: Market opportunity by geography ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Allakos Inc.
o Exhibit 85: Allakos Inc. - Overview
o Exhibit 86: Allakos Inc. - Product / Service
o Exhibit 87: Allakos Inc. - Key offerings
o 10.4 F. Hoffmann La Roche Ltd.
o Exhibit 88: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 89: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 90: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 91: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 92: F. Hoffmann La Roche Ltd. - Segment focus
o 10.5 Genentech Inc.
o Exhibit 93: Genentech Inc. - Overview
o Exhibit 94: Genentech Inc. - Product / Service
o Exhibit 95: Genentech Inc. - Key offerings
o 10.6 GlaxoSmithKline Plc
o Exhibit 96: GlaxoSmithKline Plc - Overview
o Exhibit 97: GlaxoSmithKline Plc - Business segments
o Exhibit 98: GlaxoSmithKline Plc - Key news
o Exhibit 99: GlaxoSmithKline Plc - Key offerings
o Exhibit 100: GlaxoSmithKline Plc - Segment focus
o 10.7 Meiji Holdings Co. Ltd.
o Exhibit 101: Meiji Holdings Co. Ltd. - Overview
o Exhibit 102: Meiji Holdings Co. Ltd. - Business segments
o Exhibit 103: Meiji Holdings Co. Ltd. - Key offerings
o Exhibit 104: Meiji Holdings Co. Ltd. - Segment focus
o 10.8 Novartis AG
o Exhibit 105: Novartis AG - Overview
o Exhibit 106: Novartis AG - Business segments
o Exhibit 107: Novartis AG - Key offerings
o Exhibit 108: Novartis AG - Segment focus
o 10.9 Otsuka Holdings Co. Ltd.
o Exhibit 109: Otsuka Holdings Co. Ltd. - Overview
o Exhibit 110: Otsuka Holdings Co. Ltd. - Business segments
o Exhibit 111: Otsuka Holdings Co. Ltd. - Key offerings
o Exhibit 112: Otsuka Holdings Co. Ltd. - Segment focus
o 10.10 Sanofi
o Exhibit 113: Sanofi - Overview
o Exhibit 114: Sanofi - Business segments
o Exhibit 115: Sanofi - Key news
o Exhibit 116: Sanofi - Key offerings
o Exhibit 117: Sanofi - Segment focus
o 10.11 TerSera Therapeutics LLC
o Exhibit 118: TerSera Therapeutics LLC - Overview
o Exhibit 119: TerSera Therapeutics LLC - Product / Service
o Exhibit 120: TerSera Therapeutics LLC - Key offerings
o 10.12 United BioPharma Inc.
o Exhibit 121: United BioPharma Inc. - Overview
o Exhibit 122: United BioPharma Inc. - Product / Service
o Exhibit 123: United BioPharma Inc. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 124: Inclusions checklist
o Exhibit 125: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 126: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 127: Research methodology
o Exhibit 128: Validation techniques employed for market sizing
o Exhibit 129: Information sources
o 11.5 List of abbreviations
o Exhibit 130: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Application - Market share 2021-2026 (%)
Exhibits25: Data Table on Application - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Application
Exhibits27: Data Table on Comparison by Application
Exhibits28: Chart on Acute urticaria - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Acute urticaria - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Acute urticaria - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Acute urticaria - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Chronic urticaria - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Chronic urticaria - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Chronic urticaria - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Chronic urticaria - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Application ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share by geography 2021-2026 (%)
Exhibits39: Data Table on Market share by geography 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity by geography ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Allakos Inc. - Overview
Exhibits86: Allakos Inc. - Product / Service
Exhibits87: Allakos Inc. - Key offerings
Exhibits88: F. Hoffmann La Roche Ltd. - Overview
Exhibits89: F. Hoffmann La Roche Ltd. - Business segments
Exhibits90: F. Hoffmann La Roche Ltd. - Key news
Exhibits91: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits92: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits93: Genentech Inc. - Overview
Exhibits94: Genentech Inc. - Product / Service
Exhibits95: Genentech Inc. - Key offerings
Exhibits96: GlaxoSmithKline Plc - Overview
Exhibits97: GlaxoSmithKline Plc - Business segments
Exhibits98: GlaxoSmithKline Plc - Key news
Exhibits99: GlaxoSmithKline Plc - Key offerings
Exhibits100: GlaxoSmithKline Plc - Segment focus
Exhibits101: Meiji Holdings Co. Ltd. - Overview
Exhibits102: Meiji Holdings Co. Ltd. - Business segments
Exhibits103: Meiji Holdings Co. Ltd. - Key offerings
Exhibits104: Meiji Holdings Co. Ltd. - Segment focus
Exhibits105: Novartis AG - Overview
Exhibits106: Novartis AG - Business segments
Exhibits107: Novartis AG - Key offerings
Exhibits108: Novartis AG - Segment focus
Exhibits109: Otsuka Holdings Co. Ltd. - Overview
Exhibits110: Otsuka Holdings Co. Ltd. - Business segments
Exhibits111: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits112: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits113: Sanofi - Overview
Exhibits114: Sanofi - Business segments
Exhibits115: Sanofi - Key news
Exhibits116: Sanofi - Key offerings
Exhibits117: Sanofi - Segment focus
Exhibits118: TerSera Therapeutics LLC - Overview
Exhibits119: TerSera Therapeutics LLC - Product / Service
Exhibits120: TerSera Therapeutics LLC - Key offerings
Exhibits121: United BioPharma Inc. - Overview
Exhibits122: United BioPharma Inc. - Product / Service
Exhibits123: United BioPharma Inc. - Key offerings
Exhibits124: Inclusions checklist
Exhibits125: Exclusions checklist
Exhibits126: Currency conversion rates for US$
Exhibits127: Research methodology
Exhibits128: Validation techniques employed for market sizing
Exhibits129: Information sources
Exhibits130: List of abbreviations